Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Rewiring the Chronic Pain Experience: Single-Session Model of Pain Reprocessing Therapy (PRT) at The Ottawa Hospital

30 ottobre 2026 aggiornato da: Ottawa Hospital Research Institute

Rewiring the Chronic Pain Experience: Feasibility and Pilot Testing of a Single-Session, 4-Hour Delivery Model of Pain Reprocessing Therapy (PRT) at The Ottawa Hospital (TOH)

The goal of this study is to find out if a one-time session of Pain Reprocessing Therapy (PRT) intervention improves participant's mood and pain. Participants in this 4 hours session will be 40 patients who've been referred to the The Ottawa Hospital Pain Clinic (TOHPC) for chronic pain.

The main questions of this study are:

  • Can we recruit 40 participants within 6 months?
  • Do at least 32 participants complete the session and answer follow up questions?
  • Does 1 session of PRT have a positive impact on participants' mood and pain?

Participants in this study will:

  • Attend 1 session of PRT.
  • Answer questions that relate to their experience of pain and their mood. They will answer these questions immediately before/after the session, 1 week after the session, and 1 month after the session.
  • After the session, some participants will participate in an interview to talk about their experience.

Panoramica dello studio

Stato

Reclutamento

Condizioni

Tipo di studio

Interventistico

Iscrizione (Stimato)

40

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

  • Nome: Susan Ward, MSW
  • Numero di telefono: 72123 613-737-8899
  • Email: SWard@toh.ca

Backup dei contatti dello studio

Luoghi di studio

    • Ontario
      • Ottawa, Ontario, Canada, K1H8L6
        • Reclutamento
        • The Ottawa Hospital
        • Investigatore principale:
          • Susan Ward, MSW

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Minimum age of 18 years or older at time of consent.

  • Chronic pain persisting for a minimum of 3 months, consistent with the International Association for the Study of Pain (IASP) definition of chronic pain.

  • Self-reported 1-week average pain intensity score between 4/10 and 9/10 on the Brief Pain Inventory (BPI)12 at screening.

    o Note: Individuals scoring less than 4/10 or more than 9/10 will be directed to other pain clinic workshops and available resources (e.g., Power Over Pain)

  • Referred to TOHPC and triaged by a registered nurse, nurse practitioner, or physician to the "diffuse pain" pathway;

  • Completed the initial pain clinic patient education and resource session (PERS) for patients triaged to the "diffuse pain" pathway;

  • Currently waiting for a 1st consultation with the Nurse Practitioner assigned to the "diffuse pain" pathway.

  • Able to read, write, and communicate in English at a level sufficient to engage with research team, the psychoeducational content, and to complete self-report measures.

  • Able to attend a single, in-person 4-hour group session at TOHPC in Ottawa on a scheduled weekday.

Exclusion Criteria:

  • Active mental health symptoms that significantly interfere with the ability to engage with psychoeducational content (e.g., dissociation, active psychosis), or participate in a group setting
  • Cognitive impairment that significantly limits the ability to comprehend study information, provide informed consent, or meaningfully engage with psychoeducational content.
  • Scheduled for a major surgical procedure within the study timeframe.
  • Currently receiving other individual or group psychotherapy that directly targets pain, pain cognitions, or pain-related emotional responses within the 12 weeks prior to enrollment.
  • Currently receiving interventional pain management services (e.g., injections, nerve blocks) from another clinic or institution within the 12-week period prior to enrollment through the 3-month follow-up.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: N / A
  • Modello interventistico: Assegnazione di gruppo singolo
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Pain Reprocessing Therapy (PRT) session

The intervention involves a single 4-hour PRT in-person group session (up to 20 patients per group) at The Ottawa Hospital Pain Clinic, delivered by a PRT certified clinician.

The intervention is a brief mindfulness exercise (mindfulness of breath, energy, emotions, thoughts, sensations), followed by 90 minutes of didactic content focused on pain science education and foundation of pain reprocessing therapy. This includes interactive discussions, self-reflection, and skills building. This is followed by a brief exercise called predictive coding where participants are invited to draw a picture representing their pain. The remainder of the session includes gentle movement, somatic tracking, and practices to increase positive affect induction- specifically leaning into positive or neutral sensations and establishing short-term safety behaviours.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Clinical Effectiveness: Brief Pain Inventory (BPI) Pain Intensity and Pain Interference
Lasso di tempo: Baseline, 1 week post-intervention, 1 month follow up.

Clinical effectiveness outcome measurement tools include Brief Pain Inventory (BPI): Participants will localize their pain through a drop down menu, in which they will select the applicable body part(s) where they experience pain. The BPI Pain Intensity and Pain Interference scales will then be administered. The pain intensity subscale includes 4 pain intensity ratings using an 11-point numerical rating scale (0-10) on current pain, average pain, worst pain during the last 7 days and least pain during the last 24 hours. The pain interference subscale includes 7 interference items that ask the patient to respond using an 11-point numerical rating scale (0-10). These items include the effect on general activity, mood, walking ability, normal work (including housework), relations with other people, sleep, and enjoyment of life.

Baseline, 1 week post-intervention, 1 month follow up.
Interview
Lasso di tempo: Interviews will be conducted within 6 months of participating in the PRT session.

A random selection of participants will be interviewed regarding their PRT experience.

Interviews will be conducted within 6 months of participating in the PRT session.
Clinical Effectiveness: Pain Self-Efficacy Questionnaire (PSEQ-10)
Lasso di tempo: Baseline, 1 week post-intervention, 1 month follow up.

Clinical effectiveness outcome measurement tools include Pain Self-Efficacy Questionnaire (PSEQ-10): The PSEQ-10 is a validated 10-item tool for assessing the patient's pain self-efficacy or belief in one's capability to perform activities even when undergoing pain. The 10 items ask the patient to rate their confidence in doing activities on a 7-point numerical rating scale (0-6), with higher scores indicating greater confidence.

Baseline, 1 week post-intervention, 1 month follow up.
Clinical Effectiveness: Patients' Global Impression of Change (PGI-C) Scale
Lasso di tempo: 1 week post-intervention, 1 month follow up.

Clinical effectiveness outcome measurement tools include Patients' Global Impression of Change (PGI-C) Scale: The PGI-C is a validated single- item self-report measure used to assess a patient's perceived change in overall status following a treatment or intervention. Patients select one of 7 options to describe their experience, ranging from "very much worse" to "very much improved." The PGI-C is widely used in chronic pain research and has demonstrated sensitivity to clinically meaningful change across a range of pain populations.

1 week post-intervention, 1 month follow up.
Clinical Effectiveness: Positive and Negative Affect Scale (PANAS)
Lasso di tempo: Day of Intervention, 1 week post-intervention, 1 month follow up.

Clinical effectiveness outcome measurement tools include Positive and Negative Affect Scale (PANAS) PANAS is a validated 20-item self-report measure assessing two distinct dimensions of mood: positive affect and negative affect. Participants rate the extent to which they have experienced each emotion using a 5-point Likert scale (1 = very slightly or not at all, 5 = extremely), with higher positive affect scores and lower negative affect scores reflecting better emotional well-being. The PANAS has demonstrated strong reliability and validity across clinical populations, including individuals with chronic pain.

Day of Intervention, 1 week post-intervention, 1 month follow up.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Feasibility of recruitment
Lasso di tempo: Baseline

• Rates of participant eligibility and consenting will be tracked

o The single session PRT model will be considered feasible if we can recruit our target sample size of 40 participants over a 6-month period.

Baseline
Rate of participant accrual/completion
Lasso di tempo: Baseline, Day 7, and Day 30

• Rates of participant accrual, screening, and 1-week and 1-month assessment completion will be tracked

o The evaluation procedures will be considered feasible if we retain more than 80% of participants at 1-month follow-up.

Baseline, Day 7, and Day 30

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Susan Ward, MSW, The Ottawa Hospital

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

16 ottobre 2026

Completamento primario (Stimato)

1 maggio 2027

Completamento dello studio (Stimato)

1 ottobre 2027

Date di iscrizione allo studio

Primo inviato

14 ottobre 2026

Primo inviato che soddisfa i criteri di controllo qualità

30 ottobre 2026

Primo Inserito (Effettivo)

5 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

5 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

30 ottobre 2026

Ultimo verificato

1 ottobre 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi